VacV Biotherapeutics Company Profile, Contacts & Intelligence

VacV Biotherapeutics Overview

VacV Biotherapeutics is a cancer immunotherapy company developing innovative viral-based therapies for cancers. Launched in 2022 by cancer immunotherapy pioneers Professor Yaohe Wang, Professor Nicholas Lemoine, Dr. Louisa Chard Dunmall and Dr. Peng Liu, VacV employs a unique approach to immunotherapy based on the Vaccinia virus to stimulate a patient’s immune system to fight cancer while simultaneously destroying cancer cells. This approach offers many advantages over existing immunotherapies, including minimized toxicity, higher specificity and efficacy, allowing for efficient systemic delivery of an immunotherapy for the first time.

Headquarters

London, City of, United Kingdom

Website

vacvbtx.com

Industry

Biotechnology Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

VacV Biotherapeutics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

VacV Biotherapeutics People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

VacV Biotherapeutics Workforce Composition

Seniority breakdown across 3 visible profiles.

VacV Biotherapeutics Technology & Talent

Technology-related job titles represented in the visible people data.

Compare Similar Companies to VacV Biotherapeutics

Explore companies in related markets and compare their industry and employee estimates.